You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Coloma Jason V · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$77.73K
Coloma Jason V Chief Executive Officer
MAZE
Maze Therapeutics
MAZE
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$29.81
Jul 1, 2026
First close after public filing
$32.35
Jul 6, 2026
30-day return after filing
-15.52%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,593 shares @ $29.98
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001676170-26-000014
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.03M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Sale | Jul 1, 2026 | $77.73K |
| Maze Therapeutics, Inc. MAZE | Sale | Jul 1, 2026 | $907.92K |
| Maze Therapeutics, Inc. MAZE | Sale | Jul 1, 2026 | $48.61K |